Castres (France), December 10 2015 - Pierre Fabre Laboratories (www.pierre-fabre.com), the 3rd French pharmaceutical laboratory and the 2nd dermo-cosmetic laboratory in the world, announced that members of management will participate in 2 conferences in San Francisco in January 2016: the 34th Annual JP Morgan Healthcare Conference being held from January 11 to 15 in San Francisco, where they will present their strategic priorities for 2016, and Dermatology Summit on January 10th.
During the JP Morgan Healthcare conference, Pierre Fabre executives will be available to meet with existing and potential partners, the financial community and the press in a suite at the Hilton Union Square 333 O’Farrell St, from 9:00am to 5:00pm, January 11th to 15th.
The members of Pierre Fabre’s team available at JP Morgan Healthcare :
Corporate executives :
Bertrand PARMENTIER (Chief Executive Officer Pierre Fabre Laboratories),
Frédéric DUCHESNE (Chief Executive Officer, Pierre Fabre Pharmaceuticals) ;
R&D executives :
Laurent AUDOLY (Head of R&D Pierre Fabre Pharmaceuticals),
Alexandre PASSIOUKOV (Head of Translational Medicine, Pierre Fabre Pharmaceuticals),
Maud BRANDELY (Director Clinical development, Pierre Fabre Pharmaceuticals)
Business Development executives:
Frédéric DESDOUITS (EVP Corporate Licensing & Acquisitions Pierre Fabre),
Maurice CHELLI PhD (VP Corporate Licensing and Acquisitions, Pierre Fabre),
Frédéric MOLIN (VP Corporate Licensing & Acquisitions Pierre Fabre),
Damien BAUR (VP Corporate Licensing & Acquisitions, Pierre Fabre).
For the press wishing to get appointments with Pierre Fabre’s executives, please contact Caroline Carmagnol (+ 33 6 64 18 99 59 / caroline@alizerp.com). For all other appointment requests please, contact our team (JPMorgan@pierre-fabre.com).
About Pierre Fabre
Pierre Fabre is a French privately owned health and beauty care company created in 1961 by Mr. Pierre Fabre. In 2014, global sales reached €2.1 billion across 130 countries. The company is structured around two divisions: Pharmaceuticals (prescription drugs, consumer health care) and Dermo-cosmetics (including the European and Asian market-leader Eau Thermale Avène brand). Pierre Fabre employs 10,000 people worldwide and owns subsidiary in 43 countries. In 2014, the company allocated 17 percent of its pharmaceuticals sales to R&D with a focus on 4 therapeutic areas: oncology, dermatology, CNS and consumer health care.
Pierre Fabre’s oncology know-how is based on 3 decades of experience in the discovery, development and global commercialization of innovative cancer drugs including monoclonal antibodies and natural cytotoxic agents. The company performs its oncology R&D in two major research centers: the Center of Immunology Pierre Fabre (CIPF) based in Saint-Julien-en-Genevois (France) and the Pierre Fabre Research Center (CRPF) located on the Toulouse-Oncopole campus. The latter is officially recognized as a National Center of Excellence for Cancer Research.
